Mirum Pharmaceuticals Inc (MIRM)
46.18
+2.26
(+5.13%)
USD |
NASDAQ |
Nov 14, 16:00
46.46
+0.28
(+0.62%)
After-Hours: 20:00
Mirum Pharmaceuticals Research and Development Expense (Quarterly): 32.67M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 32.67M |
| March 31, 2024 | 32.22M |
| December 31, 2023 | 30.94M |
| September 30, 2023 | 26.12M |
| June 30, 2023 | 22.01M |
| March 31, 2023 | 23.55M |
| December 31, 2022 | 31.10M |
| September 30, 2022 | 26.22M |
| June 30, 2022 | 25.43M |
| March 31, 2022 | 24.09M |
| December 31, 2021 | 27.78M |
| September 30, 2021 | 30.47M |
| Date | Value |
|---|---|
| June 30, 2021 | 35.05M |
| March 31, 2021 | 38.13M |
| December 31, 2020 | 29.73M |
| September 30, 2020 | 15.98M |
| June 30, 2020 | 18.56M |
| March 31, 2020 | 17.34M |
| December 31, 2019 | 14.38M |
| September 30, 2019 | 12.16M |
| June 30, 2019 | 11.59M |
| March 31, 2019 | 4.863M |
| September 30, 2018 | 0.003M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
14.38M
Minimum
Dec 2019
38.13M
Maximum
Mar 2021
26.41M
Average
26.22M
Median
Sep 2022
Research and Development Expense (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 19.50M |
| Cytokinetics Inc | -- |
| Amicus Therapeutics Inc | 26.16M |
| MannKind Corp | 12.93M |
| TG Therapeutics Inc | 20.14M |